Stealth BioTherapeutics (NASDAQ: MITO)
Stealth BioTherapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Stealth BioTherapeutics Company Info
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.
Valuation
Earnings Transcripts
Stealth BioTherapeutics Corp (MITO) Q3 2020 Earnings Call Transcript
MITO earnings call for the period ending September 30, 2020.
Stealth BioTherapeutics Corp (MITO) Q2 2020 Earnings Call Transcript
MITO earnings call for the period ending June 30, 2020.
Stealth BioTherapeutics Corp (MITO) Q1 2020 Earnings Call Transcript
MITO earnings call for the period ending March 31, 2020.
Stealth BioTherapeutics Corp (MITO) Q4 2019 Earnings Call Transcript
MITO earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.